Prime Medicine, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.17
|
|
Average Rating
|
4.42
|
|
# Strong Buys
|
7
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.42
|
-0.44
|
-0.02
|
-4.71%
|
|
2024-06-30
|
-0.39
|
-0.46
|
-0.07
|
-18.86%
|
|
2024-03-31
|
-0.47
|
-0.44
|
0.03
|
6.38%
|
|
2023-12-31
|
-0.51
|
-0.72
|
-0.21
|
-41.18%
|
|
2023-09-30
|
-0.46
|
-0.55
|
-0.09
|
-19.57%
|
|
2023-06-30
|
-0.42
|
-0.47
|
-0.05
|
-11.90%
|
|
2023-03-31
|
-0.41
|
-0.44
|
-0.03
|
-7.32%
|
|
2022-12-31
|
-0.65
|
-0.56
|
0.09
|
13.85%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.34
|
|
2023-12-31
|
-2.18
|
|
2022-12-31
|
-1.85
|